Physician
Infectious Disease
Dr. Cecile L. Tremblay, MD
|
|
Give Review
Cecile Tremblay is an expert in the field of Infectious Disease. Doctor Cecile L. Tremblay, MD is also a published physician. He has 57 publication published. The most recent publication is: Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy.
Publications
- Usefulness of hqSNV analysis for subtyping the highly clonal and the most prevalent Salmonella Heidelberg clone in the context of outbreak investigations.
- The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individu...
- Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.
- Synergistic combinations of the CCR5 inhibitor VCH-286 with other classes of HIV-1 inhibitors.
- Performance of a clonal-based HIV-1 tropism phenotypic assay.
- Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIV-positive patients from the general population, Cotonou, Benin.
- Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.
- Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Québec's public health...
- Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes.
- Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial.
- TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro.
- Favorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro.
- Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro.
- Virtual intervention to support self-management of antiretroviral therapy among people living with HIV.
- Evaluation of a non-isotopic polymerase chain reaction assay for detection in clinical specimens of herpes simplex virus type 2 DNA. Canadian Women''s HIV Study Group.
- In micronodular cirrhosis, hepatocytes retain a normal C-25 hydroxylation capacity toward vitamin D3: a study using the rat carbon tetrachloride-induced cirrhotic model.
- [Morbidity, mortality and etiology of gas gangrene in Canada].
- Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults.
- Correlates of unprotected anal sex at last sexual episode: analysis from a surveillance study of men who have sex with men in Montreal.
- Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice.
- Prevalence of hearing loss in northern Quebec: a medical and statistical challenge.
- Obstacles, challenges, and solutions: evolution in audiological service delivery to the hearing-impaired Inuit of northern Quebec.
- Effects of HIV-1 entry inhibitors in combination.
- Oral priming followed by parenteral immunization with HIV-immunosomes induce HIV-1-specific salivary and circulatory IgA in mice and rabbits.
- Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry.
- Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients.
- Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
- Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management: a six year follow up study.
- [Biological monitoring of exposure to polycyclic aromatic hydrocarbons among people living nearby an aluminum smelter in the province of Québec].
- Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.
- Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
- Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminum production workers in Arvida, Quebec, Canada.
- Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.
- Circulating levels of IL-7 but not IL-15, IGF-1, and TGF-beta are elevated during primary HIV-1 infection.
- A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.
- High level of primary drug resistance in Mali.
- Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patients.
- Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection.
- Evolution and transmission of stable CTL escape mutations in HIV infection.
- Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.
- Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis.
- In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.
- A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
- Wide variation in the multiplicity of HIV-1 infection among injection drug users.
- Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts.
- Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method.
- Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.
- The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
- Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy.
- Interactions among combinations of two and three protease inhibitors against drug-susceptible and drug-resistant HIV-1 isolates.
- High rates of forward transmission events after acute/early HIV-1 infection.
- Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1.
- Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection.
- Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes.
- T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers.
- Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Schools
University of Montreal Faculty of Medicine
Hotel Dieu De Mh Hospital
Hostp St Luc Notre Dame Hmr
Massachusetts General Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- MultiPlan PPO
- PHCS Network PPO
Helpful Reviews
Similar Doctors
|
|
Dr. Brian C. Zanoni, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia L. Hibberd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regina C. Larocque, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donald A. Goldmann, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Erica S. Shenoy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Kaufman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah M. Fortune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Spyridon Chalkias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter F. Weller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Werner C. Albrich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sigal Yawetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keren Z. Landman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camilla S. Graham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Albrecht, MD
This Doctor is OpenDoctor Recommended.
|